Structure-based approaches towards identification of fragments for the low-druggability ATAD2 bromodomain
Chaikuad A., Petros AM., Fedorov O., Xu J., Knapp S.
Fragments for the development of ATAD2 bromodomain inhibitors have been identified and characterized by NMR and co-crystallization.